ICU
|LMF Acquisition Opportunities Inc
NASDAQ
USD 1.19
-0.01|-0.83%
Current Price
USD 1.19
Change
USD -0.01 (-0.83%)
P/E Ratio
Dividend Yield
Market Cap
13.31M
Volume
64,227
Open
USD 1.20
Previous Close
USD 1.20
52-Week High
USD 13.85
52-Week Low
USD 1.11
About LMF Acquisition Opportunities Inc
SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI)...
Sector:Healthcare
Industry:Biotechnology
CEO:Mr. Eric Schlorff
Employees:19
Headquarters:Denver, USA
Website:seastarmedical.com
Dividend History
Dividend Payments
| Declared Date | Record Date | Payment Date | Amount | Frequency |
|---|
Similar Companies
Explore Stocks by Sector
technology
finance
healthcare
Frequently Asked Questions